Brian Durie
Hematology & Oncology · West Hollywood, CANPI 1649369414
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.6%), education and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 53.6% of the total. Reporting peaked in 2020 at $1,980 and has fallen 92.3% since, to $153 in 2025. That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.
Across 8 payments — averaging $462.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Bristol Myers Squibb$1K
- E.r. Squibb & Sons, L.L.C.$497
- BD$88
Across 18 payments — averaging $45,825 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$436K
- Pfizer$250K
- Janssen Research & Development, LLC$125K
- Regeneron$7K
- Amgen$6K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
What the payments were for
- Consulting fees$1,98054%
- Food & beverage$2697%
- Education$1,44739%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,980 |
| Bristol Myers Squibb | 2 | $1,131 |
| E.r. Squibb & Sons, L.L.C. | 4 | $497 |
| BD | 1 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,696 in reported general payments places this provider in the 50th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in West Hollywood
- Robert VescioWest Hollywood$1.1M
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.